Literature DB >> 11723095

Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance.

H Nagaretani1, T Nakamura, T Funahashi, K Kotani, M Miyanaga, K Tokunaga, M Takahashi, H Nishizawa, K Kishida, H Kuriyama, K Hotta, S Yamashita, Y Matsuzawa.   

Abstract

OBJECTIVE: The significance of abdominal visceral fat accumulation was evaluated in Japanese men with impaired glucose tolerance (IGT). RESEARCH DESIGN AND METHODS: The IGT subjects (n = 123) were aged 55 +/- 9 years with a BMI of 24 +/- 3 kg/m(2). The 148 control subjects with normal glucose tolerance (NGT) were matched for age and BMI. IGT and NGT were classified according to the 1985 World Health Organization criteria. Abdominal fat distribution was analyzed by computed tomography at umbilical level. Plasma lipid, glucose, and insulin concentrations and blood pressure (BP) were measured.
RESULTS: In subjects with IGT, the average visceral fat area (VFA) was significantly greater than in subjects with NGT. Fasting insulin, the sum of insulin concentrations during an oral glucose tolerance test, insulin resistance according to a homeostasis model assessment for insulin resistance (HOMA-IR), systolic BP, and serum triglyceride were significantly higher, whereas the DeltaI(30-0)/DeltaG(30-0) was significantly lower, in subjects with IGT. Subjects with IGT and NGT were then divided into three subgroups according to the number of risk factors they possessed (dyslipidemia, hypertension, neither, or both). In both IGT and NGT subjects, BMI, VFA, subcutaneous fat area, fasting insulin, HOMA-IR, and insulin secretion of the homeostasis model assessment were significantly higher in the double-risk factor subgroup than in the no-risk factor subgroup, and VFA was a potent and independent variable in association with the presence of a double risk factor.
CONCLUSIONS: Visceral fat accumulation is a major contributor for multiple risk factor clustering in Japanese men with IGT and NGT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723095     DOI: 10.2337/diacare.24.12.2127

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  Visceral fat accumulation and insulin resistance are important factors in nonalcoholic fatty liver disease.

Authors:  Yuichiro Eguchi; Takahisa Eguchi; Toshihiko Mizuta; Yasushi Ide; Tsutomu Yasutake; Ryuichi Iwakiri; Akitaka Hisatomi; Iwata Ozaki; Kyousuke Yamamoto; Yoichiro Kitajima; Yasunori Kawaguchi; Shigetaka Kuroki; Naofumi Ono
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

2.  Magnetic resonance imaging for quantifying regional adipose tissue in human immunodeficiency virus-infected persons with the cardiometabolic syndrome.

Authors:  Adil Bashir; Erin Laciny; Sherry Lassa-Claxton; Kevin E Yarasheski
Journal:  J Cardiometab Syndr       Date:  2008

3.  The Associations of Indices of Obesity with Lipoprotein Subfractions in Japanese American, African American and Korean Men.

Authors:  Nobutaka Hirooka; Chol Shin; Kamal H Masaki; Daniel Edmundowicz; Jina Choo; Emma J M Barinas-Mitchell; Bradley J Willcox; Kim Sutton-Tyrrell; Aiman El-Saed; Iva Miljkovic-Gacic; Takayoshi Ohkubo; Katsuyuki Miura; Hirotsugu Ueshima; Lewis H Kuller; Akira Sekikawa
Journal:  Glob Heart       Date:  2013-09-01

4.  Determinants of glycemic control in female diabetic patients: a study from Iran.

Authors:  Zeinab Ghazanfari; Shamsaddin Niknami; Fazlollah Ghofranipour; Bagher Larijani; Hamid Agha-Alinejad; Ali Montazeri
Journal:  Lipids Health Dis       Date:  2010-08-11       Impact factor: 3.876

5.  Relation of blood pressure and body mass index during childhood to cardiovascular risk factor levels in young adults.

Authors:  Erin R Rademacher; David R Jacobs; Antoinette Moran; Julia Steinberger; Ronald J Prineas; Alan Sinaiko
Journal:  J Hypertens       Date:  2009-09       Impact factor: 4.844

6.  Association between metabolic syndrome and age-related cataract.

Authors:  Sangshin Park; Eun-Hee Lee
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

7.  Proof of Concept: Matrix metalloproteinase inhibitor decreases inflammation and improves muscle insulin sensitivity in people with type 2 diabetes.

Authors:  Karen Frankwich; Courtney Tibble; Moises Torres-Gonzalez; Mariah Bonner; Roy Lefkowitz; Matt Tyndall; Geert W Schmid-Schönbein; Francisco Villarreal; Mike Heller; Karen Herbst
Journal:  J Inflamm (Lond)       Date:  2012-10-01       Impact factor: 4.981

8.  Effects of a moderate low-carbohydrate diet on preferential abdominal fat loss and cardiovascular risk factors in patients with type 2 diabetes.

Authors:  Tae Sasakabe; Hajime Haimoto; Hiroyuki Umegaki; Kenji Wakai
Journal:  Diabetes Metab Syndr Obes       Date:  2011-04-29       Impact factor: 3.168

9.  Effect of longitudinal changes in visceral fat area and other anthropometric indices to the changes in metabolic risk factors in Japanese men: the Hitachi Health Study.

Authors:  Yumi Matsushita; Toru Nakagawa; Shuichiro Yamamoto; Yoshihiko Takahashi; Tetsuji Yokoyama; Tetsuya Mizoue; Mitsuhiko Noda
Journal:  Diabetes Care       Date:  2012-03-19       Impact factor: 19.112

10.  Angiotensin 1-7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model.

Authors:  Yonit Marcus; Gabi Shefer; Keren Sasson; Fortune Kohen; Rona Limor; Orit Pappo; Nava Nevo; Inbal Biton; Michal Bach; Tamara Berkutzki; Matityahu Fridkin; Dafna Benayahu; Yoram Shechter; Naftali Stern
Journal:  Diabetes       Date:  2012-12-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.